Breast implants have been popular for over 50 years and their limitations and risks are well known. Our surgeons discuss the risks of surgery with prospective patients in detail before each patient decides to proceed or not with surgery.
Serious complications are rare, and there are no recent studies in this field.
However one issue is current in the media - a low-grade lymphoma - Anaplastic Large Cell Lymphoma (ALCL). It is rare, 1 in 24,000 patients, and generally curable. It has been associated with textured implants and particularly those made by Allergan and to a lesser extent Mentor. The French Society of Plastic and Reconstructive Surgery (SOFCPRE) working alongside the American Society of Plastic Surgeons (ASPS) has advised that surgeons should avoid using biocell macro-textured implants or polyurethane implants until more data is available on the associated risk of ALCL. There is no present concern about micro-textured or smooth implants. However, they do not recommend the removal of any implants as the risk of ALCL is minimal.
How does this affect Cadogan Clinic patients?
+ We do not currently use macro-textured implants or polyurethane implants + We have not seen either ALCL or Breast Implant Illness in any of the patients we have implanted in 10 years. + Our patients are entered on Breast and Cosmetic Implant Registry (BCIR), so that they can be contacted if any new issues arise needing treatment. + We provide potential patients with up to date information on these and other risks, including notices put out by our associations BAPRAS and BAAPS + Patients showing symptoms (e.g. unilateral increase in breast size after a number of years post-implant) should speak to their doctor who can arrange an ultrasound or an MRI scan. If fluid has built up around the implant (seroma), the doctor may advise a test of the ALCL biomarker + We are happy to discuss any concerns our existing/previous patients have in greater detail – please call 0207 901 8500